Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile

Date: February 13, 2018
Pages: 45
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G4D6551FCDEEN
Leaflet:

Download PDF Leaflet

Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile
Summary

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deal Details
Venture Financing
Epic Sciences Raises USD40 Million in Series D Venture Financing
InVitae Raises USD120 Million in Series F Venture Financing
Invitae Raises US$40 Million In Series E Financing
Partnerships
Genomic Health Enters into Licensing Agreement with Cleveland Diagnostics
Genomic Health Enters into Licensing Agreement with Biocartis
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Genomic Health Enters into Research Agreement with Janssen Pharma
Genomic Health and Epic Sciences Enter into Distribution Agreement
Philips Electronics Enters into Agreement with Genomic Health
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma
Equity Offering
Biocartis Group Raises USD4 Million in Private Placement
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million
Genomic Health Inc - Key Competitors
Genomic Health Inc - Key Employees
Genomic Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Nov 08, 2017: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress
Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress
Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook
Product News
Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types
May 30, 2017: Genomic Health Announces Presentation of Eight Oncotype DX Studies at the 2017 American Society of Clinical Oncology Annual Meeting Reinforcing Unique Impact Across Cancer Types
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deal Details
Venture Financing
Epic Sciences Raises USD40 Million in Series D Venture Financing
InVitae Raises USD120 Million in Series F Venture Financing
Invitae Raises US$40 Million In Series E Financing
Partnerships
Genomic Health Enters into Licensing Agreement with Cleveland Diagnostics
Genomic Health Enters into Licensing Agreement with Biocartis
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Genomic Health Enters into Research Agreement with Janssen Pharma
Genomic Health and Epic Sciences Enter into Distribution Agreement
Philips Electronics Enters into Agreement with Genomic Health
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma
Equity Offering
Biocartis Group Raises USD4 Million in Private Placement
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million
Genomic Health Inc - Key Competitors
Genomic Health Inc - Key Employees
Genomic Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Nov 08, 2017: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress
Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress
Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook
Product News
Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types
May 30, 2017: Genomic Health Announces Presentation of Eight Oncotype DX Studies at the 2017 American Society of Clinical Oncology Annual Meeting Reinforcing Unique Impact Across Cancer Types
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF FIGURES

Genomic Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Genomic Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: